Humacyte, Inc

Theodore D. Lithgow, Ph.D.

Chief Operating Officer

Dr. Lithgow is a psychopharmacologist by training, and most recently President and CSO of Meadwestvaco Corporation Healthcare.

He was formerly senior commercial lead and representative for Schering Plough/Merck global prescription pharmaceutical business, with former responsibility for all cross-Customer divisional initiatives and process at Schering Plough (S-P), and a previous Group Vice-President and General Manager of the Respiratory Joint Venture between the S-P and Merck pharmaceutical organizations. Dr. Lithgow was formerly Vice-President, Commercial Operations and Emerging Technologies at Pharmacia Corporation (Peapack, N.J.).

Dr. Lithgow was a Director of New Products Marketing Global CNS, Psychiatry and Neurology at Wyeth Corporation (Philadelphia, Pa.) and previous Director, U.S. Women’s Health Care Prescription Therapeutics, Contraception and Reproductive Disorders.

Dr. Lithgow is the author of articles in peer reviewed journals, and writes extensively on patient adherence and pharmaceutical packaging.